Cropropamide

• CAT Number: R018629
• CAS Number: 633-47-6
• Molecular Formula: C13H24N2O2
• Molecular Weight: 240.35
• Purity: ≥95%
• Synonyms: N-[1-[(Dimethylamino)carbonyl]propyl]-N-propyl-2-butenamide; N-[1-(dimethylcarbamoyl)propyl]-N-propylcrotonamide; Propylbutamide?
• Storage: -20°C
• IUPAC Name: 2-[[(E)-but-2-enoyl]-propylamino]-N,N-dimethylbutanamide
• InChI: InChI=1S/C13H24N2O2/c1-6-9-12(16)15(10-7-2)11(8-3)13(17)14(4)5/h6,9,11H,7-8,10H2,1-5H3/b9-6+
• InChIKey: CYZWCBZIBJLKCV-RMKNXTFCSA-N
• SMILES: CCCN(C(CC)C(=O)N(C)C)C(=O)/C=C/C

Cropropamide（Cat No.:R018629）is a sulfonylurea-class oral antidiabetic drug with the molecular formula C13H24N2O2. It is used to lower blood glucose levels in individuals with type 2 diabetes mellitus by stimulating insulin release from pancreatic beta cells. Structurally, it contains a sulfonylurea core substituted with a cyclopropyl group, contributing to its pharmacological activity. Though once explored for clinical use, it has largely been replaced by more effective and better-tolerated agents. Cropropamide may cause side effects such as hypoglycemia or gastrointestinal discomfort and should be administered with appropriate medical supervision and dietary regulation.